Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 27;12:1756286419835708. doi: 10.1177/1756286419835708

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Day 90 functional outcome at 3 months according to time to reperfusion.

Distribution of mRS scores at 3 months, according to time to reperfusion strata. Analysis was done using multivariable binary logistic regression analysis adjusting for prespecified confounders outlined in the methods section for TTR per hour increase. The thick green line proposed by Goyal and colleagues indicates a highly significant beneficial treatment effect with higher rate of the primary outcome mRS 0–2 (aOR 0.933, 95% CI 0.887–0.981, p = 0.007). The thin green line indicates a significant beneficial treatment effect with higher rate of mRS 0–1 (aOR 0.929, 95% CI 0.877–0.985, p = 0.013) and mRS 0–3 (aOR 0.955, 95% CI 0.911–1.000, p = 0.049). The thin red line indicates a beneficial, but non-significant, treatment effect for mortality (aOR 0.988, 95% CI 0.933–1.046, p = 0.680).

mRS, modified Rankin scale.